Biblio
Export 1093 results:
[ Author
Filters: First Letter Of Keyword is C [Clear All Filters]
“Caspase signalling controls microglia activation and neurotoxicity.”, Nature, vol. 472, no. 7343, pp. 319-24, 2011.
, “Caspase signalling controls microglia activation and neurotoxicity.”, Nature, vol. 472, no. 7343, pp. 319-24, 2011.
, “Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.”, J Alzheimers Dis, vol. 61, no. 2, pp. 705-715, 2018.
, “Aphasia in Progressive Supranuclear Palsy: As Severe as Progressive Non-Fluent Aphasia.”, J Alzheimers Dis, vol. 61, no. 2, pp. 705-715, 2018.
, “Neural Computation-Based Methods for the Early Diagnosis and Prognosis of Alzheimer's Disease Not Using Neuroimaging Biomarkers: A Systematic Review.”, J Alzheimers Dis, vol. 98, no. 3, pp. 793-823, 2024.
, “Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 51, no. 1, pp. 27-31, 2016.
, “Brain Metabolism Correlates of the Free and Cued Selective Reminding Test in Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 51, no. 1, pp. 27-31, 2016.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
, “Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults.”, J Alzheimers Dis, vol. 28, no. 1, pp. 93-107, 2012.
, “Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults.”, J Alzheimers Dis, vol. 28, no. 1, pp. 93-107, 2012.
, “Neuroinflammation, hyperphosphorylated tau, diffuse amyloid plaques, and down-regulation of the cellular prion protein in air pollution exposed children and young adults.”, J Alzheimers Dis, vol. 28, no. 1, pp. 93-107, 2012.
, “Environmental Nanoparticles, SARS-CoV-2 Brain Involvement, and Potential Acceleration of Alzheimer's and Parkinson's Diseases in Young Urbanites Exposed to Air Pollution.”, J Alzheimers Dis, vol. 78, no. 2, pp. 479-503, 2020.
, “Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 2, pp. 545-552, 2018.
, “Increased Serum Acylated Ghrelin Levels in Patients with Mild Cognitive Impairment.”, J Alzheimers Dis, vol. 61, no. 2, pp. 545-552, 2018.
, “Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.”, J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
, “Telemedicine for Delivery of Care in Frontotemporal Lobar Degeneration During COVID-19 Pandemic: Results from Southern Italy.”, J Alzheimers Dis, vol. 76, no. 2, pp. 481-489, 2020.
, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
, “Needs of Dementia Family Caregivers in Spain During the COVID-19 Pandemic.”, J Alzheimers Dis, vol. 80, no. 2, pp. 533-537, 2021.
, “Cerebrospinal Fluid Anti-Amyloid-β Autoantibodies and Amyloid PET in Cerebral Amyloid Angiopathy-Related Inflammation.”, J Alzheimers Dis, vol. 50, no. 1, pp. 1-7, 2016.
, “Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.”, J Alzheimers Dis, vol. 97, no. 1, pp. 121-143, 2024.
, “Sleep Biomarkers for Predicting Cognitive Decline and Alzheimer's Disease: A Systematic Review of Longitudinal Studies.”, J Alzheimers Dis, vol. 97, no. 1, pp. 121-143, 2024.
, “Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
, “Apolipoprotein ɛ4 is Associated with Dementia and Cognitive Impairment Predominantly Due to Alzheimer's Disease and Not with Vascular Cognitive Impairment: A Singapore-Based Cohort.”, J Alzheimers Dis, vol. 51, no. 4, pp. 1111-8, 2016.
, “Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.”, J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
, “Potential Impact of Slowing Disease Progression in Early Symptomatic Alzheimer's Disease on Patient Quality of Life, Caregiver Time, and Total Societal Costs: Estimates Based on Findings from GERAS-US Study.”, J Alzheimers Dis, vol. 100, no. 2, pp. 563-578, 2024.
,